Log In
Print this Print this

Xpansion Interpreter

  Manage Alerts
Collapse Summary General Information
Company Asuragen Inc.
DescriptionTest that determines the total number of CGG repeats and number of AGG interruptions in the Fragile X mental retardation 1 (FMR1) gene
Molecular Target Fragile X mental retardation 1 (FMR1)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationFragile X syndrome
Indication DetailsDiagnose the risk of having a child with Fragile X syndrome
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today